Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Medulloblastoma × fludarabine × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Multiple Myeloma 12 Myelodysplastic Syndromes 11 Lymphoma 11 Lymphoma, Non-Hodgkin 9 Leukemia, Lymphocytic, Chronic, B-Cell 9 Recurrence 8 Lymphoma, Large B-Cell, Diffuse 8 Myeloproliferative Disorders 6 Lymphoma, B-Cell 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Lymphoma, Follicular 5 Leukemia, Biphenotypic, Acute 5 Leukemia 5 Hodgkin Disease 5 Pancreatic Neoplasms 4 Neoplasms 4 Melanoma 4 Lymphoma, Mantle-Cell 4 Hematologic Neoplasms 4 Burkitt Lymphoma 4 Anemia, Refractory, with Excess of Blasts 4 Primary Myelofibrosis 3 Ovarian Neoplasms 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Myelomonocytic, Chronic 3 Urogenital Neoplasms 2 Sarcoma 2 Rhabdomyosarcoma 2

Interventions

Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Temozolomide 3 Cyclophosphamide 3 etoposide phosphate 2 X-Rays 2 Phantoms, Imaging 2 Nuclear Medicine Department, Hospital 2 Irinotecan 2 Etoposide 2 Eflornithine 2 Celecoxib 2 Biopsy 2 sodium thiosulfate 1 pembrolizumab 1 fenofibric acid 1 erdafitinib 1 ensartinib 1 dinutuximab 1 abemaciclib 1 Vincristine 1 Thalidomide 1 Sirolimus 1 Radiotherapy 1 Radiation 1 Platinum 1 Nivolumab 1 Lomustine 1 LY2940680 1 Hearing 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡